Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7698)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 30, 2021 (publication date) through Feb 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li H, Fu ZY, Arslan ME, Cho D, Lee H. Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review. World J Exp Med 2021; 11(6): 79-92 [PMID: PMC9553980 DOI: 10.5493/wjem.v11.i6.79] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/79.htm |
| Number | Citing Articles |
| 1 |
Masashi Kono, Yoriaki Komeda, Hisato Kawakami, Satoru Hagiwara, George Tribonias, Kohei Handa, Shunsuke Omoto, Mamoru Takenaka, Hiroshi Kashida, Naoko Tsuji, Masatoshi Kudo. JAK Inhibitor Upadacitinib Induces Remission in Refractory Immune‐Related Colitis Triggered by CTLA‐4 and PD‐1 Inhibitor Combination Therapy in Malignant Pleural Mesothelioma: A Case Report. Cancer Reports 2024; 7(10) doi: 10.1002/cnr2.70032
|
| 2 |
O. Gómez Escudero. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist. Revista de Gastroenterología de México (English Edition) 2024; 89(1): 89 doi: 10.1016/j.rgmxen.2023.11.001
|
| 3 |
O. Gómez-Escudero. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo. Revista de Gastroenterología de México 2024; 89(1): 89 doi: 10.1016/j.rgmx.2023.11.001
|
| 4 |
Sara Kiparizoska, Megan E. Murphy, Mark C. Mattar. Check this out: treatment paradigms in immune-checkpoint inhibitor colitis. Current Opinion in Gastroenterology 2023; 39(1): 43 doi: 10.1097/MOG.0000000000000892
|
| 5 |
Casey Fazer-Posorske, Lisa Kottschade, Anna Schwecke. The Basics of Cancer Immunotherapy. 2024; : 179 doi: 10.1007/978-3-031-59475-5_14
|
| 6 |
Skaistė Astašauskaitė, Rita Kupčinskaitė-Noreikienė, Inga Zaborienė, Rūta Vaičiūnienė, Tomas Vanagas, Darius Pranys, Lina Poškienė, Elona Juozaitytė. Multiorgan Toxicity from Dual Checkpoint Inhibitor Therapy, Resulting in a Complete Response—A Case Report. Medicina 2024; 60(7): 1129 doi: 10.3390/medicina60071129
|
| 7 |
Andreja Ocepek. Colitis due to cancer treatment with immune check-point inhibitors – review of literature and presentation of clinical cases. Radiology and Oncology 2024; 58(2): 179 doi: 10.2478/raon-2024-0022
|
| 8 |
Masaya Iwamuro, Takehiro Tanaka, Shunsuke Kagawa, Shoko Inoo, Motoyuki Otsuka. Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy. Cureus 2023; doi: 10.7759/cureus.39466
|
| 9 |
Angelo Del Gaudio, Federica Di Vincenzo, Valentina Petito, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases 2024; 30(6): 1018 doi: 10.1093/ibd/izad229
|
| 10 |
Maria Terrin, Giulia Migliorisi, Arianna Dal Buono, Roberto Gabbiadini, Elisabetta Mastrorocco, Alessandro Quadarella, Alessandro Repici, Armando Santoro, Alessandro Armuzzi. Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management. International Journal of Molecular Sciences 2023; 24(14): 11504 doi: 10.3390/ijms241411504
|
| 11 |
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, Marina Cipullo, Mario Romeo, Giovanna Palladino, Patrizia Iodice, Alessandro Federico, Teresa Troiani. The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review. Cancers 2024; 16(3): 611 doi: 10.3390/cancers16030611
|
| 12 |
Marianne Zoghbi, Kathryn J. Burk, Elio Haroun, Maria Saade, Maria Teresa Cruz Carreras. Immune checkpoint inhibitor-induced diarrhea and colitis: an overview. Supportive Care in Cancer 2024; 32(10) doi: 10.1007/s00520-024-08889-2
|
| 13 |
Qianjie Xu, Xiaosheng Li, Yuliang Yuan, Guangzhong Liang, Zuhai Hu, Wei Zhang, Ying Wang, Haike Lei. Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in China. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1510053
|